Treatment of Chin Retrusion With Botulinum Toxin Plus Hyaluronic Acid Filler in Comparison With Hyaluronic Acid Filler Alone: A Randomized, Evaluator-Blinded, Controlled Study.

Aesthetic surgery journal 2024 Vol.44(5) p. 537-544

Guo Y, Wang J, Wei W, Zhang A, Li Q, Tao C, Shen C, Wei H, Jin P

관련 도메인

Abstract

[BACKGROUND] Hyaluronic acid (HA) has already been widely administered for chin augmentation. Patients with chin retrusion frequently present with increased chin hypertonia. Monotherapy with HA falls short in addressing the multifaceted cosmetic concerns associated with chin retrusion.

[OBJECTIVES] This study aimed to investigate the clinical efficacy and safety of the combination therapy involving botulinum toxin (BTX) and HA in the treatment of chin retrusion.

[METHODS] We enrolled patients with moderate to severe chin retrusion for 9 months of follow-up after they received either combined treatment with BTX plus HA or monotreatment with HA. We also calculated the surface-volume coefficient with 3-dimensional digital scanning technique, and evaluated outcomes based on the Allergan Chin Retrusion Scale (ACRS), the Global Aesthetic Improvement Scale (GAIS), and treatment-related adverse events (TRAEs).

[RESULTS] A total of 50 patients were recruited and randomized to the treatment group (BTX plus HA) or control group (HA alone) in a 1:1 ratio. Patients in the treatment group exhibited significantly higher surface-volume coefficients during the first 6 months (P < .05). ACRS scores and responder rates in the 2 groups remained similar throughout the follow-up (P > .05). Within the initial 3 months, the GAIS responder rate in the treatment group was significantly higher than that in the control group (P < .05). Mild TRAEs were observed in both groups, and subsided within 7 days. There was no increase in adverse effects with the combined treatment.

[CONCLUSIONS] In comparison to monotherapy, the combined treatment not only improved the surface-volume coefficient of hyaluronic acid but also achieved similar ACRS scores with less HA volume. Furthermore, the combination treatment yielded superior treatment outcomes for individuals with chin retrusion.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
재료 ha 히알루론산 dict 8
재료 hyaluronic acid 히알루론산 dict 4
시술 botulinum toxin 보툴리눔독소 주사 dict 2
시술 hyaluronic acid filler 필러 주입술 dict 2
시술 chin augmentation 턱끝성형술 dict 1
해부 Retrusion scispacy 1
합병증 chin retrusion scispacy 1
약물 monotreatment scispacy 1
약물 [BACKGROUND] Hyaluronic acid scispacy 1
약물 [OBJECTIVES] scispacy 1
약물 [RESULTS] A scispacy 1
약물 BTX → botulinum toxin scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 chin hypertonia scispacy 1
질환 ACRS → Allergan Chin Retrusion Scale scispacy 1
질환 TRAEs → treatment-related adverse events scispacy 1
질환 BTX → botulinum toxin scispacy 1
기타 Patients scispacy 1
기타 chin retrusion scispacy 1
기타 BTX → botulinum toxin scispacy 1

MeSH Terms

Humans; Chin; Cosmetic Techniques; Hyaluronic Acid; Botulinum Toxins; Treatment Outcome; Dermal Fillers; Skin Aging

📑 인용 관계

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문